"ID"	"Description"	"GeneRatio"	"BgRatio"	"pvalue"	"p.adjust"	"qvalue"	"geneID"	"Count"
"R-HSA-76009"	"Platelet Aggregation (Plug Formation)"	"2/33"	"39/10654"	0.00641784213901448	0.263888621315151	0.240362568072232	"151/5908"	2
"R-HSA-1793185"	"Chondroitin sulfate/dermatan sulfate metabolism"	"2/33"	"50/10654"	0.0103871866128716	0.263888621315151	0.240362568072232	"411/221914"	2
"R-HSA-428157"	"Sphingolipid metabolism"	"2/33"	"89/10654"	0.0308108945879664	0.263888621315151	0.240362568072232	"411/8879"	2
"R-HSA-2980736"	"Peptide hormone metabolism"	"2/33"	"90/10654"	0.0314509614620179	0.263888621315151	0.240362568072232	"10159/3798"	2
"R-HSA-1839122"	"Signaling by activated point mutants of FGFR1"	"1/33"	"11/10654"	0.0335644215756534	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-189451"	"Heme biosynthesis"	"1/33"	"11/10654"	0.0335644215756534	0.263888621315151	0.240362568072232	"211"	1
"R-HSA-2206281"	"Mucopolysaccharidoses"	"1/33"	"11/10654"	0.0335644215756534	0.263888621315151	0.240362568072232	"411"	1
"R-HSA-5625970"	"RHO GTPases activate KTN1"	"1/33"	"11/10654"	0.0335644215756534	0.263888621315151	0.240362568072232	"3798"	1
"R-HSA-8875555"	"MET activates RAP1 and RAC1"	"1/33"	"11/10654"	0.0335644215756534	0.263888621315151	0.240362568072232	"5908"	1
"R-HSA-1839130"	"Signaling by activated point mutants of FGFR3"	"1/33"	"12/10654"	0.0365609802609866	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-190373"	"FGFR1c ligand binding and activation"	"1/33"	"12/10654"	0.0365609802609866	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-2033514"	"FGFR3 mutant receptor activation"	"1/33"	"12/10654"	0.0365609802609866	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-1663150"	"The activation of arylsulfatases"	"1/33"	"13/10654"	0.0395485284334527	0.263888621315151	0.240362568072232	"411"	1
"R-HSA-190239"	"FGFR3 ligand binding and activation"	"1/33"	"13/10654"	0.0395485284334527	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-190372"	"FGFR3c ligand binding and activation"	"1/33"	"13/10654"	0.0395485284334527	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-190375"	"FGFR2c ligand binding and activation"	"1/33"	"13/10654"	0.0395485284334527	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-5654227"	"Phospholipase C-mediated cascade; FGFR3"	"1/33"	"13/10654"	0.0395485284334527	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-5658623"	"FGFRL1 modulation of FGFR1 signaling"	"1/33"	"13/10654"	0.0395485284334527	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-879415"	"Advanced glycosylation endproduct receptor signaling"	"1/33"	"13/10654"	0.0395485284334527	0.263888621315151	0.240362568072232	"3958"	1
"R-HSA-2187338"	"Visual phototransduction"	"2/33"	"103/10654"	0.0402402230716825	0.263888621315151	0.240362568072232	"221914/3292"	2
"R-HSA-190322"	"FGFR4 ligand binding and activation"	"1/33"	"14/10654"	0.0425270923430195	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-2024101"	"CS/DS degradation"	"1/33"	"14/10654"	0.0425270923430195	0.263888621315151	0.240362568072232	"411"	1
"R-HSA-3656237"	"Defective EXT2 causes exostoses 2"	"1/33"	"14/10654"	0.0425270923430195	0.263888621315151	0.240362568072232	"221914"	1
"R-HSA-3656253"	"Defective EXT1 causes exostoses 1, TRPS2 and CHDS"	"1/33"	"14/10654"	0.0425270923430195	0.263888621315151	0.240362568072232	"221914"	1
"R-HSA-71240"	"Tryptophan catabolism"	"1/33"	"14/10654"	0.0425270923430195	0.263888621315151	0.240362568072232	"169355"	1
"R-HSA-8964539"	"Glutamate and glutamine metabolism"	"1/33"	"14/10654"	0.0425270923430195	0.263888621315151	0.240362568072232	"2752"	1
"R-HSA-354194"	"GRB2:SOS provides linkage to MAPK signaling for Integrins "	"1/33"	"15/10654"	0.0454966981656399	0.263888621315151	0.240362568072232	"5908"	1
"R-HSA-372708"	"p130Cas linkage to MAPK signaling for integrins"	"1/33"	"15/10654"	0.0454966981656399	0.263888621315151	0.240362568072232	"5908"	1
"R-HSA-5654228"	"Phospholipase C-mediated cascade; FGFR4"	"1/33"	"15/10654"	0.0454966981656399	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-189445"	"Metabolism of porphyrins"	"1/33"	"16/10654"	0.0484573720034563	0.263888621315151	0.240362568072232	"211"	1
"R-HSA-190242"	"FGFR1 ligand binding and activation"	"1/33"	"16/10654"	0.0484573720034563	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-392517"	"Rap1 signalling"	"1/33"	"16/10654"	0.0484573720034563	0.263888621315151	0.240362568072232	"5908"	1
"R-HSA-5654219"	"Phospholipase C-mediated cascade: FGFR1"	"1/33"	"16/10654"	0.0484573720034563	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-1989781"	"PPARA activates gene expression"	"2/33"	"117/10654"	0.0506161944721823	0.263888621315151	0.240362568072232	"211/7296"	2
"R-HSA-2033519"	"Activated point mutants of FGFR2"	"1/33"	"17/10654"	0.0514091398850027	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-4655427"	"SUMOylation of DNA methylation proteins"	"1/33"	"17/10654"	0.0514091398850027	0.263888621315151	0.240362568072232	"80012"	1
"R-HSA-400206"	"Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)"	"2/33"	"119/10654"	0.0521702933741141	0.263888621315151	0.240362568072232	"211/7296"	2
"R-HSA-8878166"	"Transcriptional regulation by RUNX2"	"2/33"	"121/10654"	0.053741557097272	0.263888621315151	0.240362568072232	"3958/8493"	2
"R-HSA-2022377"	"Metabolism of Angiotensinogen to Angiotensins"	"1/33"	"18/10654"	0.0543520277654003	0.263888621315151	0.240362568072232	"10159"	1
"R-HSA-5654221"	"Phospholipase C-mediated cascade; FGFR2"	"1/33"	"18/10654"	0.0543520277654003	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-5654704"	"SHC-mediated cascade:FGFR3"	"1/33"	"18/10654"	0.0543520277654003	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-5654710"	"PI-3K cascade:FGFR3"	"1/33"	"18/10654"	0.0543520277654003	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-1630316"	"Glycosaminoglycan metabolism"	"2/33"	"124/10654"	0.0561300747723457	0.263888621315151	0.240362568072232	"411/221914"	2
"R-HSA-9007101"	"Rab regulation of trafficking"	"2/33"	"124/10654"	0.0561300747723457	0.263888621315151	0.240362568072232	"57589/55357"	2
"R-HSA-6798695"	"Neutrophil degranulation"	"4/33"	"480/10654"	0.0593519957827855	0.263888621315151	0.240362568072232	"411/10159/3958/5908"	4
"R-HSA-190241"	"FGFR2 ligand binding and activation"	"1/33"	"20/10654"	0.0602112669773994	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-3560783"	"Defective B4GALT7 causes EDS, progeroid type"	"1/33"	"20/10654"	0.0602112669773994	0.263888621315151	0.240362568072232	"221914"	1
"R-HSA-3560801"	"Defective B3GAT3 causes JDSSDHD"	"1/33"	"20/10654"	0.0602112669773994	0.263888621315151	0.240362568072232	"221914"	1
"R-HSA-388844"	"Receptor-type tyrosine-protein phosphatases"	"1/33"	"20/10654"	0.0602112669773994	0.263888621315151	0.240362568072232	"26280"	1
"R-HSA-4420332"	"Defective B3GALT6 causes EDSP2 and SEMDJL1"	"1/33"	"20/10654"	0.0602112669773994	0.263888621315151	0.240362568072232	"221914"	1
"R-HSA-5654706"	"FRS-mediated FGFR3 signaling"	"1/33"	"20/10654"	0.0602112669773994	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-5654719"	"SHC-mediated cascade:FGFR4"	"1/33"	"20/10654"	0.0602112669773994	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-5654720"	"PI-3K cascade:FGFR4"	"1/33"	"20/10654"	0.0602112669773994	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-5654688"	"SHC-mediated cascade:FGFR1"	"1/33"	"21/10654"	0.0631276698539973	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-5654689"	"PI-3K cascade:FGFR1"	"1/33"	"21/10654"	0.0631276698539973	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-2024096"	"HS-GAG degradation"	"1/33"	"22/10654"	0.0660352958198414	0.263888621315151	0.240362568072232	"221914"	1
"R-HSA-392154"	"Nitric oxide stimulates guanylate cyclase"	"1/33"	"22/10654"	0.0660352958198414	0.263888621315151	0.240362568072232	"4842"	1
"R-HSA-5654712"	"FRS-mediated FGFR4 signaling"	"1/33"	"22/10654"	0.0660352958198414	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-5655332"	"Signaling by FGFR3 in disease"	"1/33"	"22/10654"	0.0660352958198414	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-8853338"	"Signaling by FGFR3 point mutants in cancer"	"1/33"	"22/10654"	0.0660352958198414	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-2453902"	"The canonical retinoid cycle in rods (twilight vision)"	"1/33"	"23/10654"	0.0689341704659987	0.263888621315151	0.240362568072232	"3292"	1
"R-HSA-5654693"	"FRS-mediated FGFR1 signaling"	"1/33"	"23/10654"	0.0689341704659987	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-5654695"	"PI-3K cascade:FGFR2"	"1/33"	"23/10654"	0.0689341704659987	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-5654699"	"SHC-mediated cascade:FGFR2"	"1/33"	"23/10654"	0.0689341704659987	0.263888621315151	0.240362568072232	"2249"	1
"R-HSA-5654700"	"FRS-mediated FGFR2 signaling"	"1/33"	"25/10654"	0.0747057678026405	0.273008422491506	0.248669325749513	"2249"	1
"R-HSA-5654708"	"Downstream signaling of activated FGFR3"	"1/33"	"25/10654"	0.0747057678026405	0.273008422491506	0.248669325749513	"2249"	1
"R-HSA-1971475"	"A tetrasaccharide linker sequence is required for GAG synthesis"	"1/33"	"26/10654"	0.0775785413149668	0.273008422491506	0.248669325749513	"221914"	1
"R-HSA-264876"	"Insulin processing"	"1/33"	"27/10654"	0.0804426651516816	0.273008422491506	0.248669325749513	"3798"	1
"R-HSA-354192"	"Integrin alphaIIb beta3 signaling"	"1/33"	"27/10654"	0.0804426651516816	0.273008422491506	0.248669325749513	"5908"	1
"R-HSA-5654716"	"Downstream signaling of activated FGFR4"	"1/33"	"27/10654"	0.0804426651516816	0.273008422491506	0.248669325749513	"2249"	1
"R-HSA-76066"	"RNA Polymerase III Transcription Initiation From Type 2 Promoter"	"1/33"	"27/10654"	0.0804426651516816	0.273008422491506	0.248669325749513	"9330"	1
"R-HSA-9006921"	"Integrin signaling"	"1/33"	"27/10654"	0.0804426651516816	0.273008422491506	0.248669325749513	"5908"	1
"R-HSA-76061"	"RNA Polymerase III Transcription Initiation From Type 1 Promoter"	"1/33"	"28/10654"	0.0832981645447362	0.273008422491506	0.248669325749513	"9330"	1
"R-HSA-5654732"	"Negative regulation of FGFR3 signaling"	"1/33"	"29/10654"	0.0861450646548459	0.273008422491506	0.248669325749513	"2249"	1
"R-HSA-499943"	"Interconversion of nucleotide di- and triphosphates"	"1/33"	"30/10654"	0.0889833905716825	0.273008422491506	0.248669325749513	"7296"	1
"R-HSA-5654696"	"Downstream signaling of activated FGFR2"	"1/33"	"30/10654"	0.0889833905716825	0.273008422491506	0.248669325749513	"2249"	1
"R-HSA-1839124"	"FGFR1 mutant receptor activation"	"1/33"	"31/10654"	0.091813167314071	0.273008422491506	0.248669325749513	"2249"	1
"R-HSA-2022928"	"HS-GAG biosynthesis"	"1/33"	"31/10654"	0.091813167314071	0.273008422491506	0.248669325749513	"221914"	1
"R-HSA-4641262"	"Disassembly of the destruction complex and recruitment of AXIN to the membrane"	"1/33"	"31/10654"	0.091813167314071	0.273008422491506	0.248669325749513	"8321"	1
"R-HSA-5339562"	"Uptake and actions of bacterial toxins"	"1/33"	"31/10654"	0.091813167314071	0.273008422491506	0.248669325749513	"7296"	1
"R-HSA-5654687"	"Downstream signaling of activated FGFR1"	"1/33"	"31/10654"	0.091813167314071	0.273008422491506	0.248669325749513	"2249"	1
"R-HSA-5654733"	"Negative regulation of FGFR4 signaling"	"1/33"	"31/10654"	0.091813167314071	0.273008422491506	0.248669325749513	"2249"	1
"R-HSA-1839126"	"FGFR2 mutant receptor activation"	"1/33"	"33/10654"	0.0974471729977203	0.273008422491506	0.248669325749513	"2249"	1
"R-HSA-5654726"	"Negative regulation of FGFR1 signaling"	"1/33"	"33/10654"	0.0974471729977203	0.273008422491506	0.248669325749513	"2249"	1
"R-HSA-5654727"	"Negative regulation of FGFR2 signaling"	"1/33"	"34/10654"	0.100251451624128	0.273008422491506	0.248669325749513	"2249"	1
"R-HSA-5663084"	"Diseases of carbohydrate metabolism"	"1/33"	"34/10654"	0.100251451624128	0.273008422491506	0.248669325749513	"411"	1
"R-HSA-196071"	"Metabolism of steroid hormones"	"1/33"	"35/10654"	0.103047280446765	0.273008422491506	0.248669325749513	"3292"	1
"R-HSA-8953750"	"Transcriptional Regulation by E2F6"	"1/33"	"35/10654"	0.103047280446765	0.273008422491506	0.248669325749513	"80012"	1
"R-HSA-1222556"	"ROS and RNS production in phagocytes"	"1/33"	"36/10654"	0.105834684133106	0.273008422491506	0.248669325749513	"4842"	1
"R-HSA-6802948"	"Signaling by high-kinase activity BRAF mutants"	"1/33"	"36/10654"	0.105834684133106	0.273008422491506	0.248669325749513	"5908"	1
"R-HSA-76046"	"RNA Polymerase III Transcription Initiation"	"1/33"	"36/10654"	0.105834684133106	0.273008422491506	0.248669325749513	"9330"	1
"R-HSA-71291"	"Metabolism of amino acids and derivatives"	"3/33"	"372/10654"	0.106824233609316	0.273008422491506	0.248669325749513	"2752/169355/7296"	3
"R-HSA-3299685"	"Detoxification of Reactive Oxygen Species"	"1/33"	"37/10654"	0.108613687280931	0.273008422491506	0.248669325749513	"7296"	1
"R-HSA-5655302"	"Signaling by FGFR1 in disease"	"1/33"	"38/10654"	0.111384314418515	0.273008422491506	0.248669325749513	"2249"	1
"R-HSA-8939243"	"RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known"	"1/33"	"38/10654"	0.111384314418515	0.273008422491506	0.248669325749513	"80012"	1
"R-HSA-8950505"	"Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation"	"1/33"	"38/10654"	0.111384314418515	0.273008422491506	0.248669325749513	"5908"	1
"R-HSA-163841"	"Gamma carboxylation, hypusine formation and arylsulfatase activation"	"1/33"	"39/10654"	0.114146590004818	0.273008422491506	0.248669325749513	"411"	1
"R-HSA-5654741"	"Signaling by FGFR3"	"1/33"	"40/10654"	0.116900538429673	0.273008422491506	0.248669325749513	"2249"	1
"R-HSA-5674135"	"MAP2K and MAPK activation"	"1/33"	"40/10654"	0.116900538429673	0.273008422491506	0.248669325749513	"5908"	1
"R-HSA-3560782"	"Diseases associated with glycosaminoglycan metabolism"	"1/33"	"41/10654"	0.119646184013979	0.273008422491506	0.248669325749513	"221914"	1
"R-HSA-5654743"	"Signaling by FGFR4"	"1/33"	"41/10654"	0.119646184013979	0.273008422491506	0.248669325749513	"2249"	1
"R-HSA-74158"	"RNA Polymerase III Transcription"	"1/33"	"41/10654"	0.119646184013979	0.273008422491506	0.248669325749513	"9330"	1
"R-HSA-749476"	"RNA Polymerase III Abortive And Retractive Initiation"	"1/33"	"41/10654"	0.119646184013979	0.273008422491506	0.248669325749513	"9330"	1
"R-HSA-8875878"	"MET promotes cell motility"	"1/33"	"41/10654"	0.119646184013979	0.273008422491506	0.248669325749513	"5908"	1
"R-HSA-375280"	"Amine ligand-binding receptors"	"1/33"	"42/10654"	0.122383551009884	0.273008422491506	0.248669325749513	"151"	1
"R-HSA-1660661"	"Sphingolipid de novo biosynthesis"	"1/33"	"43/10654"	0.125112663600977	0.273008422491506	0.248669325749513	"8879"	1
"R-HSA-5655253"	"Signaling by FGFR2 in disease"	"1/33"	"43/10654"	0.125112663600977	0.273008422491506	0.248669325749513	"2249"	1
"R-HSA-975634"	"Retinoid metabolism and transport"	"1/33"	"43/10654"	0.125112663600977	0.273008422491506	0.248669325749513	"221914"	1
"R-HSA-109704"	"PI3K Cascade"	"1/33"	"44/10654"	0.127833545902472	0.273008422491506	0.248669325749513	"2249"	1
"R-HSA-6811438"	"Intra-Golgi traffic"	"1/33"	"44/10654"	0.127833545902472	0.273008422491506	0.248669325749513	"57589"	1
"R-HSA-6811442"	"Intra-Golgi and retrograde Golgi-to-ER traffic"	"2/33"	"202/10654"	0.129001824461903	0.273008422491506	0.248669325749513	"3798/57589"	2
"R-HSA-418594"	"G alpha (i) signalling events"	"3/33"	"406/10654"	0.129643144910489	0.273008422491506	0.248669325749513	"151/221914/3292"	3
"R-HSA-3899300"	"SUMOylation of transcription cofactors"	"1/33"	"45/10654"	0.130546221961399	0.273008422491506	0.248669325749513	"80012"	1
"R-HSA-1660662"	"Glycosphingolipid metabolism"	"1/33"	"46/10654"	0.133250715756788	0.273008422491506	0.248669325749513	"411"	1
"R-HSA-8854214"	"TBC/RABGAPs"	"1/33"	"46/10654"	0.133250715756788	0.273008422491506	0.248669325749513	"55357"	1
"R-HSA-4570464"	"SUMOylation of RNA binding proteins"	"1/33"	"47/10654"	0.135947051199852	0.273008422491506	0.248669325749513	"80012"	1
"R-HSA-6802946"	"Signaling by moderate kinase activity BRAF mutants"	"1/33"	"47/10654"	0.135947051199852	0.273008422491506	0.248669325749513	"5908"	1
"R-HSA-6802949"	"Signaling by RAS mutants"	"1/33"	"47/10654"	0.135947051199852	0.273008422491506	0.248669325749513	"5908"	1
"R-HSA-6802955"	"Paradoxical activation of RAF signaling by kinase inactive BRAF"	"1/33"	"47/10654"	0.135947051199852	0.273008422491506	0.248669325749513	"5908"	1
"R-HSA-6806667"	"Metabolism of fat-soluble vitamins"	"1/33"	"47/10654"	0.135947051199852	0.273008422491506	0.248669325749513	"221914"	1
"R-HSA-9020591"	"Interleukin-12 signaling"	"1/33"	"47/10654"	0.135947051199852	0.273008422491506	0.248669325749513	"5908"	1
"R-HSA-9649948"	"Signaling downstream of RAS mutants"	"1/33"	"47/10654"	0.135947051199852	0.273008422491506	0.248669325749513	"5908"	1
"R-HSA-112399"	"IRS-mediated signalling"	"1/33"	"48/10654"	0.138635252134179	0.273916425587692	0.249496379053021	"2249"	1
"R-HSA-418597"	"G alpha (z) signalling events"	"1/33"	"48/10654"	0.138635252134179	0.273916425587692	0.249496379053021	"151"	1
"R-HSA-6811440"	"Retrograde transport at the Trans-Golgi-Network"	"1/33"	"49/10654"	0.141315342335911	0.276978070978385	0.252285074317584	"57589"	1
"R-HSA-1483249"	"Inositol phosphate metabolism"	"1/33"	"50/10654"	0.143987345513932	0.277770863393018	0.253007188138861	"253430"	1
"R-HSA-5654736"	"Signaling by FGFR1"	"1/33"	"50/10654"	0.143987345513932	0.277770863393018	0.253007188138861	"2249"	1
"R-HSA-2428928"	"IRS-related events triggered by IGF1R"	"1/33"	"52/10654"	0.149307185299183	0.283567910064339	0.258287419693405	"2249"	1
"R-HSA-72165"	"mRNA Splicing - Minor Pathway"	"1/33"	"52/10654"	0.149307185299183	0.283567910064339	0.258287419693405	"6431"	1
"R-HSA-2428924"	"IGF1R signaling cascade"	"1/33"	"53/10654"	0.151955068989536	0.286376860787972	0.260845948386896	"2249"	1
"R-HSA-2404192"	"Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"	"1/33"	"54/10654"	0.154594959822792	0.286937614822607	0.26135671038622	"2249"	1
"R-HSA-74751"	"Insulin receptor signalling cascade"	"1/33"	"54/10654"	0.154594959822792	0.286937614822607	0.26135671038622	"2249"	1
"R-HSA-1638091"	"Heparan sulfate/heparin (HS-GAG) metabolism"	"1/33"	"55/10654"	0.157226881174287	0.289628465321055	0.263807667660853	"221914"	1
"R-HSA-2151201"	"Transcriptional activation of mitochondrial biogenesis"	"1/33"	"56/10654"	0.159850856353195	0.290099702270613	0.26423689315304	"211"	1
"R-HSA-5578775"	"Ion homeostasis"	"1/33"	"56/10654"	0.159850856353195	0.290099702270613	0.26423689315304	"4842"	1
"R-HSA-447115"	"Interleukin-12 family signaling"	"1/33"	"57/10654"	0.162466908602709	0.292679357409292	0.266586568295467	"5908"	1
"R-HSA-72187"	"mRNA 3'-end processing"	"1/33"	"58/10654"	0.165075061100219	0.293481795619812	0.267317467975941	"6431"	1
"R-HSA-194315"	"Signaling by Rho GTPases"	"3/33"	"455/10654"	0.16530811345116	0.293481795619812	0.267317467975941	"392/79019/3798"	3
"R-HSA-983189"	"Kinesins"	"1/33"	"59/10654"	0.167675336957494	0.295224366153141	0.268904685819403	"3798"	1
"R-HSA-8878171"	"Transcriptional regulation by RUNX1"	"2/33"	"239/10654"	0.168699637801795	0.295224366153141	0.268904685819403	"3958/80012"	2
"R-HSA-8943724"	"Regulation of PTEN gene transcription"	"1/33"	"61/10654"	0.172852350871394	0.300346283429017	0.273569976743079	"80012"	1
"R-HSA-6790901"	"rRNA modification in the nucleus and cytosol"	"1/33"	"62/10654"	0.175429134825065	0.302677028395359	0.275692932415966	"10199"	1
"R-HSA-1226099"	"Signaling by FGFR in disease"	"1/33"	"63/10654"	0.177998133932956	0.304961837857162	0.277774047801153	"2249"	1
"R-HSA-5673001"	"RAF/MAP kinase cascade"	"2/33"	"249/10654"	0.179782893410566	0.305083075106525	0.277884476573935	"2249/5908"	2
"R-HSA-4608870"	"Asymmetric localization of PCP proteins"	"1/33"	"64/10654"	0.180559370981413	0.305083075106525	0.277884476573935	"8321"	1
"R-HSA-5684996"	"MAPK1/MAPK3 signaling"	"2/33"	"255/10654"	0.186489622839036	0.311541895157344	0.283767483451587	"2249/5908"	2
"R-HSA-6802952"	"Signaling by BRAF and RAF fusions"	"1/33"	"67/10654"	0.188196736666477	0.311541895157344	0.283767483451587	"5908"	1
"R-HSA-73856"	"RNA Polymerase II Transcription Termination"	"1/33"	"67/10654"	0.188196736666477	0.311541895157344	0.283767483451587	"6431"	1
"R-HSA-76002"	"Platelet activation, signaling and aggregation"	"2/33"	"262/10654"	0.194362042122868	0.319584114037253	0.291092726856703	"151/5908"	2
"R-HSA-1257604"	"PIP3 activates AKT signaling"	"2/33"	"264/10654"	0.196620041057426	0.319584114037253	0.291092726856703	"2249/80012"	2
"R-HSA-4551638"	"SUMOylation of chromatin organization proteins"	"1/33"	"71/10654"	0.198272593198622	0.319584114037253	0.291092726856703	"80012"	1
"R-HSA-6802957"	"Oncogenic MAPK signaling"	"1/33"	"71/10654"	0.198272593198622	0.319584114037253	0.291092726856703	"5908"	1
"R-HSA-9607240"	"FLT3 Signaling"	"2/33"	"267/10654"	0.20001383872125	0.320283597952328	0.29172985076646	"2249/5908"	2
"R-HSA-5654738"	"Signaling by FGFR2"	"1/33"	"73/10654"	0.203264939677646	0.322883848924876	0.294098285594302	"2249"	1
"R-HSA-606279"	"Deposition of new CENPA-containing nucleosomes at the centromere"	"1/33"	"74/10654"	0.20574979526697	0.322883848924876	0.294098285594302	"79019"	1
"R-HSA-774815"	"Nucleosome assembly"	"1/33"	"74/10654"	0.20574979526697	0.322883848924876	0.294098285594302	"79019"	1
"R-HSA-159236"	"Transport of Mature mRNA derived from an Intron-Containing Transcript"	"1/33"	"75/10654"	0.208227135225022	0.322883848924876	0.294098285594302	"6431"	1
"R-HSA-2219530"	"Constitutive Signaling by Aberrant PI3K in Cancer"	"1/33"	"75/10654"	0.208227135225022	0.322883848924876	0.294098285594302	"2249"	1
"R-HSA-5693565"	"Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks"	"1/33"	"76/10654"	0.210696981575109	0.324372933466643	0.295454616089917	"8314"	1
"R-HSA-3108214"	"SUMOylation of DNA damage response and repair proteins"	"1/33"	"77/10654"	0.21315935627808	0.324372933466643	0.295454616089917	"80012"	1
"R-HSA-5693606"	"DNA Double Strand Break Response"	"1/33"	"77/10654"	0.21315935627808	0.324372933466643	0.295454616089917	"8314"	1
"R-HSA-74752"	"Signaling by Insulin receptor"	"1/33"	"78/10654"	0.215614281232493	0.326083326555313	0.297012525154571	"2249"	1
"R-HSA-6806834"	"Signaling by MET"	"1/33"	"79/10654"	0.218061778274789	0.327761568572535	0.298541149462417	"5908"	1
"R-HSA-72202"	"Transport of Mature Transcript to Cytoplasm"	"1/33"	"84/10654"	0.230188604753167	0.338124143589975	0.307979885890761	"6431"	1
"R-HSA-5683057"	"MAPK family signaling cascades"	"2/33"	"294/10654"	0.23085938825354	0.338124143589975	0.307979885890761	"2249/5908"	2
"R-HSA-71387"	"Metabolism of carbohydrates"	"2/33"	"295/10654"	0.23201012580978	0.338124143589975	0.307979885890761	"411/221914"	2
"R-HSA-5628897"	"TP53 Regulates Metabolic Genes"	"1/33"	"86/10654"	0.234988097326471	0.338124143589975	0.307979885890761	"7296"	1
"R-HSA-190236"	"Signaling by FGFR"	"1/33"	"87/10654"	0.237376949785615	0.338124143589975	0.307979885890761	"2249"	1
"R-HSA-5368286"	"Mitochondrial translation initiation"	"1/33"	"87/10654"	0.237376949785615	0.338124143589975	0.307979885890761	"29088"	1
"R-HSA-5389840"	"Mitochondrial translation elongation"	"1/33"	"87/10654"	0.237376949785615	0.338124143589975	0.307979885890761	"29088"	1
"R-HSA-5419276"	"Mitochondrial translation termination"	"1/33"	"87/10654"	0.237376949785615	0.338124143589975	0.307979885890761	"29088"	1
"R-HSA-6794362"	"Protein-protein interactions at synapses"	"1/33"	"87/10654"	0.237376949785615	0.338124143589975	0.307979885890761	"26280"	1
"R-HSA-418346"	"Platelet homeostasis"	"1/33"	"88/10654"	0.239758568093278	0.33954248082574	0.309271776305293	"4842"	1
"R-HSA-9006925"	"Intracellular signaling by second messengers"	"2/33"	"305/10654"	0.243540545629172	0.342300261928985	0.311783697224253	"2249/80012"	2
"R-HSA-8876198"	"RAB GEFs exchange GTP for GDP on RABs"	"1/33"	"90/10654"	0.244500187092132	0.342300261928985	0.311783697224253	"57589"	1
"R-HSA-983168"	"Antigen processing: Ubiquitination & Proteasome degradation"	"2/33"	"309/10654"	0.248162624779066	0.344956018261773	0.314202689028984	"11146/11275"	2
"R-HSA-4086400"	"PCP/CE pathway"	"1/33"	"92/10654"	0.249213123397281	0.344956018261773	0.314202689028984	"8321"	1
"R-HSA-5368287"	"Mitochondrial translation"	"1/33"	"93/10654"	0.251558888113044	0.346246784200539	0.315378381312628	"29088"	1
"R-HSA-1592230"	"Mitochondrial biogenesis"	"1/33"	"95/10654"	0.256229115295447	0.348052949237601	0.3170235241176	"211"	1
"R-HSA-373080"	"Class B/2 (Secretin family receptors)"	"1/33"	"95/10654"	0.256229115295447	0.348052949237601	0.3170235241176	"8321"	1
"R-HSA-141424"	"Amplification of signal from the kinetochores"	"1/33"	"96/10654"	0.258553619433646	0.348052949237601	0.3170235241176	"79019"	1
"R-HSA-141444"	"Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal"	"1/33"	"96/10654"	0.258553619433646	0.348052949237601	0.3170235241176	"79019"	1
"R-HSA-6803157"	"Antimicrobial peptides"	"1/33"	"97/10654"	0.260871078285578	0.349253629398724	0.318117161901308	"10578"	1
"R-HSA-6811434"	"COPI-dependent Golgi-to-ER retrograde traffic"	"1/33"	"99/10654"	0.265484942824089	0.353498972782075	0.321984026766058	"3798"	1
"R-HSA-195258"	"RHO GTPase Effectors"	"2/33"	"327/10654"	0.269005835362575	0.353836171439423	0.322291163674147	"79019/3798"	2
"R-HSA-15869"	"Metabolism of nucleotides"	"1/33"	"101/10654"	0.270070873710906	0.353836171439423	0.322291163674147	"7296"	1
"R-HSA-2219528"	"PI3K/AKT Signaling in Cancer"	"1/33"	"101/10654"	0.270070873710906	0.353836171439423	0.322291163674147	"2249"	1
"R-HSA-5689603"	"UCH proteinases"	"1/33"	"102/10654"	0.272353415278948	0.354928652890118	0.323286248819355	"8314"	1
"R-HSA-6811558"	"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"	"1/33"	"103/10654"	0.274629034810391	0.356000600680137	0.324262630909513	"2249"	1
"R-HSA-5668914"	"Diseases of metabolism"	"1/33"	"104/10654"	0.276897752642944	0.357052365250112	0.325220629142959	"411"	1
"R-HSA-8856825"	"Cargo recognition for clathrin-mediated endocytosis"	"1/33"	"106/10654"	0.281414564273193	0.360976797104358	0.328795192206762	"85021"	1
"R-HSA-199418"	"Negative regulation of the PI3K/AKT network"	"1/33"	"110/10654"	0.290366255606181	0.368599650899038	0.335738457532099	"2249"	1
"R-HSA-73886"	"Chromosome Maintenance"	"1/33"	"110/10654"	0.290366255606181	0.368599650899038	0.335738457532099	"79019"	1
"R-HSA-69618"	"Mitotic Spindle Checkpoint"	"1/33"	"112/10654"	0.294801455656547	0.37230080740131	0.339109650565318	"79019"	1
"R-HSA-2408522"	"Selenoamino acid metabolism"	"1/33"	"118/10654"	0.30794637636796	0.386906985693078	0.352413666882632	"7296"	1
"R-HSA-2132295"	"MHC class II antigen presentation"	"1/33"	"123/10654"	0.318718698932664	0.397873865993826	0.362402833902002	"3798"	1
"R-HSA-983169"	"Class I MHC mediated antigen processing & presentation"	"2/33"	"371/10654"	0.319923067758301	0.397873865993826	0.362402833902002	"11146/11275"	2
"R-HSA-2559580"	"Oxidative Stress Induced Senescence"	"1/33"	"125/10654"	0.322981944934288	0.399649376307579	0.364020054896699	"80012"	1
"R-HSA-2500257"	"Resolution of Sister Chromatid Cohesion"	"1/33"	"126/10654"	0.325103855449737	0.400253490377817	0.364570311321578	"79019"	1
"R-HSA-5663202"	"Diseases of signal transduction"	"2/33"	"377/10654"	0.326828549568248	0.400364973221104	0.36467185530773	"2249/5908"	2
"R-HSA-8856688"	"Golgi-to-ER retrograde transport"	"1/33"	"133/10654"	0.339777700743027	0.41415689891563	0.377234210827555	"3798"	1
"R-HSA-194840"	"Rho GTPase cycle"	"1/33"	"138/10654"	0.350069108123354	0.424588769753573	0.386736065253523	"392"	1
"R-HSA-5663220"	"RHO GTPases Activate Formins"	"1/33"	"140/10654"	0.354141965448402	0.425317556543424	0.387399879644279	"79019"	1
"R-HSA-6807070"	"PTEN Regulation"	"1/33"	"140/10654"	0.354141965448402	0.425317556543424	0.387399879644279	"80012"	1
"R-HSA-5576891"	"Cardiac conduction"	"1/33"	"141/10654"	0.356169102136647	0.425665512309651	0.387716814649392	"4842"	1
"R-HSA-3781865"	"Diseases of glycosylation"	"1/33"	"143/10654"	0.36020488280653	0.428399011104854	0.390206618063282	"221914"	1
"R-HSA-3858494"	"Beta-catenin independent WNT signaling"	"1/33"	"146/10654"	0.366212594210925	0.431252827620885	0.392806012698722	"8321"	1
"R-HSA-8856828"	"Clathrin-mediated endocytosis"	"1/33"	"146/10654"	0.366212594210925	0.431252827620885	0.392806012698722	"85021"	1
"R-HSA-112316"	"Neuronal System"	"2/33"	"413/10654"	0.367885065194959	0.431252827620885	0.392806012698722	"2752/26280"	2
"R-HSA-8957322"	"Metabolism of steroids"	"1/33"	"151/10654"	0.376104087780358	0.438788102410418	0.399669506814215	"3292"	1
"R-HSA-5693532"	"DNA Double-Strand Break Repair"	"1/33"	"166/10654"	0.404888714777685	0.470131446068876	0.42821854593599	"8314"	1
"R-HSA-983231"	"Factors involved in megakaryocyte development and platelet production"	"1/33"	"168/10654"	0.408627980551829	0.472235166203765	0.430134716370346	"3798"	1
"R-HSA-500792"	"GPCR ligand binding"	"2/33"	"468/10654"	0.428810462204207	0.49323269126775	0.449260281627338	"151/8321"	2
"R-HSA-3108232"	"SUMO E3 ligases SUMOylate target proteins"	"1/33"	"182/10654"	0.434172277402634	0.494486390043862	0.450402211339629	"80012"	1
"R-HSA-9006934"	"Signaling by Receptor Tyrosine Kinases"	"2/33"	"473/10654"	0.434213682958591	0.494486390043862	0.450402211339629	"2249/5908"	2
"R-HSA-72163"	"mRNA Splicing - Major Pathway"	"1/33"	"183/10654"	0.435955347957038	0.494486390043862	0.450402211339629	"6431"	1
"R-HSA-6791226"	"Major pathway of rRNA processing in the nucleolus and cytosol"	"1/33"	"185/10654"	0.439505157690348	0.495241993761637	0.451090451890299	"10199"	1
"R-HSA-2262752"	"Cellular responses to stress"	"2/33"	"479/10654"	0.440664304653212	0.495241993761637	0.451090451890299	"80012/7296"	2
"R-HSA-2990846"	"SUMOylation"	"1/33"	"188/10654"	0.444789285170674	0.496649312949441	0.452372306531822	"80012"	1
"R-HSA-196854"	"Metabolism of vitamins and cofactors"	"1/33"	"189/10654"	0.44653990179492	0.496649312949441	0.452372306531822	"221914"	1
"R-HSA-2467813"	"Separation of Sister Chromatids"	"1/33"	"190/10654"	0.448285165363078	0.496649312949441	0.452372306531822	"79019"	1
"R-HSA-72172"	"mRNA Splicing"	"1/33"	"191/10654"	0.450025091733779	0.496649312949441	0.452372306531822	"6431"	1
"R-HSA-8953897"	"Cellular responses to external stimuli"	"2/33"	"493/10654"	0.455570011016052	0.497547895565938	0.453190779205065	"80012/7296"	2
"R-HSA-2559583"	"Cellular Senescence"	"1/33"	"195/10654"	0.456931740825862	0.497547895565938	0.453190779205065	"80012"	1
"R-HSA-8868773"	"rRNA processing in the nucleus and cytosol"	"1/33"	"195/10654"	0.456931740825862	0.497547895565938	0.453190779205065	"10199"	1
